Sulfoxide‐Mediated Cys‐Trp‐Selective Bioconjugation that Enables Protein Labeling and Peptide Heterodimerization

Author:

Kobayashi Daishiro1,Denda Masaya1ORCID,Hayashi Junya1,Hidaka Kota1,Kohmura Yutaka1,Tsunematsu Takaaki2ORCID,Nishino Kohei3,Yoshikawa Harunori3ORCID,Ohkawachi Kento1,Nigorikawa Kiyomi4ORCID,Yoshimaru Tetsuro5ORCID,Ishimaru Naozumi2ORCID,Nomura Wataru4ORCID,Katagiri Toyomasa56ORCID,Kosako Hidetaka3ORCID,Otaka Akira1ORCID

Affiliation:

1. Institute of Biomedical Sciences and Graduate School of Pharmaceutical Sciences Tokushima University Tokushima 770-8505 Japan

2. Department of Oral Molecular Pathology Graduate School of Biomedical Sciences Tokushima University Tokushima 770-8504 Japan

3. Fujii Memorial Institute of Medical Sciences Institute of Advanced Medical Sciences Tokushima University Tokushima 770-8503 Japan

4. Graduate School of Biomedical and Health Sciences and School of Pharmaceutical Sciences Hiroshima University Minami-ku Hiroshima 734-8553 Japan

5. Institute of Advanced Medical Sciences Tokushima University Tokushima 770-8503 Japan

6. National Institute of Biomedical Innovation National Institutes of Biomedical Innovation, Health and Nutrition Ibaragi Osaka 567-0085 Japan

Abstract

AbstractA method was developed that enables the magnesium chloride (MgCl2)‐activated S‐acetamidomethyl cysteine sulfoxide (Cys(Acm)(O)) to induce the sp2(C−H) sulfenylation of the indole of Trp residues. The reaction operates under mild acidic conditions using acetic acid or an ionic liquid to give the Trp‐sulfenylated products. Other than Trp, all other proteinogenic amino acids are unreactive to the sulfenylation conditions. We demonstrated the successful application of this reaction to various peptides, including lysozyme. Furthermore, we achieved the Trp‐modification of a monoclonal antibody by a MgCl2‐mediated reaction in an acidic ionic liquid. The resulting antibody exhibited antibody performance comparable to the parent protein. The amide moiety in the Acm group contributes to the difference in chemical behaviors between S‐Acm and S‐p‐methoxybenzyl (MBzl)‐protected cysteine sulfoxides. This is because the S‐Acm sulfoxide is converted to S‐chlorocysteine responsible for Trp‐sulfenylation under less acidic conditions than those required for the reaction of S‐MBzl sulfoxide. Based on this rationale, we prepared a linker possessing S‐Acm and S‐MBzl oxide moieties and subjected the linker to heterodimerization of DNA‐binding MYC and MAX peptides containing a Trp handle. The one‐pot/stepwise Cys‐Trp conjugation between the linker and DNA‐binding peptides allowed the generation of a heterodimeric MYC/MAX DNA binder.

Funder

Japan Agency for Medical Research and Development

Publisher

Wiley

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3